Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT).

Literature DB >> 18717914

Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT).

J M Ritter¹.

Abstract

Entities: Disease

Mesh：

Year: 2008 PMID： 18717914 PMCID： PMC2492935 DOI： 10.1111/j.1365-2125.2008.03255.x

Source DB: PubMed Journal: Br J Clin Pharmacol ISSN： 0306-5251 Impact factor: 4.335

× No keyword cloud information.

12 in total

1. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

Authors: A L Waldo; A J Camm; H deRuyter; P L Friedman; D J MacNeil; J F Pauls; B Pitt; C M Pratt; P J Schwartz; E P Veltri
Journal: Lancet Date: 1996-07-06 Impact factor: 79.321

2. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

Authors: Anushka Patel; Stephen MacMahon; John Chalmers; Bruce Neal; Laurent Billot; Mark Woodward; Michel Marre; Mark Cooper; Paul Glasziou; Diederick Grobbee; Pavel Hamet; Stephen Harrap; Simon Heller; Lisheng Liu; Giuseppe Mancia; Carl Erik Mogensen; Changyu Pan; Neil Poulter; Anthony Rodgers; Bryan Williams; Severine Bompoint; Bastiaan E de Galan; Rohina Joshi; Florence Travert
Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245

3. Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey.

Authors: Laurent Sailler; Camille Attane; Fleur Michenot; Jean-Marie Canonge; Lionel Rostaing; Elizabeth Arlet-Suau; Philippe Arlet; François Launay; Jean-Louis Montastruc; Maryse Lapeyre-Mestre
Journal: Br J Clin Pharmacol Date: 2008-04-10 Impact factor: 4.335

4. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

Authors: Christopher J L Murray; Jeremy A Lauer; Raymond C W Hutubessy; Louis Niessen; Niels Tomijima; Anthony Rodgers; Carlene M M Lawes; David B Evans
Journal: Lancet Date: 2003-03-01 Impact factor: 79.321

5. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

Authors:
Journal: N Engl J Med Date: 1989-08-10 Impact factor: 91.245

6. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Authors:
Journal: Lancet Date: 1990-07-07 Impact factor: 79.321

Review 7. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

Authors: Matthieu Roustit; Malik Jlaiel; Pascale Leclercq; Françoise Stanke-Labesque
Journal: Br J Clin Pharmacol Date: 2008-05-15 Impact factor: 4.335

8. Effects of intensive glucose lowering in type 2 diabetes.

Authors: Hertzel C Gerstein; Michael E Miller; Robert P Byington; David C Goff; J Thomas Bigger; John B Buse; William C Cushman; Saul Genuth; Faramarz Ismail-Beigi; Richard H Grimm; Jeffrey L Probstfield; Denise G Simons-Morton; William T Friedewald
Journal: N Engl J Med Date: 2008-06-06 Impact factor: 91.245

Chronic disease: when in doubt, consider accrual into a randomized controlled trial (RCT).

1. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

2. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.

3. Rituximab off-label use for immune diseases: assessing adverse events in a single-centre drug-utilization survey.

4. Effectiveness and costs of interventions to lower systolic blood pressure and cholesterol: a global and regional analysis on reduction of cardiovascular-disease risk.

5. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.

6. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.

Review 7. Pharmacokinetics and therapeutic drug monitoring of antiretrovirals in pregnant women.

8. Effects of intensive glucose lowering in type 2 diabetes.

9. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group.

10. Pharmacokinetics of darunavir/ritonavir and ketoconazole following co-administration in HIV-healthy volunteers.

1. Two cheers or three for treatment guidelines? Nudging prescribers in right directions.

2. Drug-induced long QT syndrome and drug development.